These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15113813)

  • 1. Combined antiretroviral therapy during pregnancy and risk of congenital malformations.
    Frieden IJ; Haggstrom AN; McCulloch C; Drolet B; Esterly NB; Garzon MC; Lucky AW; Baselga E; Friedlander SF
    JAMA; 2004 Apr; 291(16):1961-2; author reply 1962. PubMed ID: 15113813
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemangiomas and other congenital malformations in infants exposed to antiretroviral therapy in utero.
    De Santis M; Cavaliere AF; Caruso A; Villa P; Tamburrini E; Cauda R; Fundaro C; Genovese O
    JAMA; 2004 Jan; 291(3):305. PubMed ID: 14734592
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.
    Townsend CL; Willey BA; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2009 Feb; 23(4):519-24. PubMed ID: 19165088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?
    Patel D; Thorne C; Fiore S; Newell ML;
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):116-8. PubMed ID: 16123696
    [No Abstract]   [Full Text] [Related]  

  • 5. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 8. [HAART and pregnancy. Nelfinavir superiority in hepatotoxicity].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():45. PubMed ID: 15373048
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 10. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
    Silf K; McMaster P; Hendriksz C
    AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
    Martorell C; Theroux E; Bermudez A; Garb J; Kronschnabel D; Oie K
    Pediatr Infect Dis J; 2010 Oct; 29(10):985. PubMed ID: 20859183
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV and pregnancy].
    Petry KU
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth defect rates unchanged by antiretrovirals.
    AIDS Patient Care STDS; 2007 Jun; 21(6):436. PubMed ID: 17594253
    [No Abstract]   [Full Text] [Related]  

  • 14. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects and complications. Risk of deformities very low in infants exposed to HAART.
    TreatmentUpdate; 2009 Feb; 21(2):8-9. PubMed ID: 19391265
    [No Abstract]   [Full Text] [Related]  

  • 16. Zidovudine use in pregnancy and congenital malformations.
    Rough K; Sun JW; Seage GR; Williams PL; Huybrechts KF; Bateman BT; Hernandez-Diaz S
    AIDS; 2017 Jul; 31(12):1733-1743. PubMed ID: 28537936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More data on safety of antiretrovirals in pregnancy.
    Feinberg J
    AIDS Clin Care; 2002 Mar; 14(3):23. PubMed ID: 12141240
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy.
    Esker S; Albano J; Uy J; Arikan D; Jimenez-Exposito MJ; Seekins D; Tilson H
    AIDS Patient Care STDS; 2012 Jun; 26(6):307-11. PubMed ID: 22404239
    [No Abstract]   [Full Text] [Related]  

  • 19. An atypical case of multifocal infantile haemangioma in a child after Highly Active Antiretroviral Therapy (HAART) during pregnancy.
    Tchidjou HK; Vescio F; Avellis L; Aquilani A; Santilli V; Mora N; Pontrelli G; Palma P; Martino AM; Bernardi S; Rossi P; Rezza G
    Clin Neurol Neurosurg; 2012 Oct; 114(8):1161-3. PubMed ID: 22763192
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.
    Scarsi KK; Postelnick MJ
    J Gend Specif Med; 2003; 6(1):7-16. PubMed ID: 12661172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.